These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
409 related items for PubMed ID: 15127161
1. Pentoxifylline enhances tumor oxygenation and radiosensitivity in rat rhabdomyosarcomas during continuous hyperfractionated irradiation. Zywietz F, Böhm L, Sagowski C, Kehrl W. Strahlenther Onkol; 2004 May; 180(5):306-14. PubMed ID: 15127161 [Abstract] [Full Text] [Related]
2. Oxygenation of tumor recurrences following fractionated radiotherapy of primary tumors. Studies on the rhabdomyosarcoma R1H of the rat. Kehrl W, Sagowski C, Wenzel S, Zywietz F. Strahlenther Onkol; 2004 Jun; 180(6):383-90. PubMed ID: 15175874 [Abstract] [Full Text] [Related]
3. [Cytotoxicity of pentoxifylline and its effect on human hepatoma cell line Hep3b radiosensitivity]. Wu DH, Liu L, Chen LH. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):305-7. PubMed ID: 16546733 [Abstract] [Full Text] [Related]
4. No effect of the hemoglobin solution HBOC-201 on the response of the rat R1H tumor to fractionated irradiation. Raabe A, Gottschalk A, Hommel M, Dubben HH, Strandl T. Strahlenther Onkol; 2005 Nov; 181(11):730-7. PubMed ID: 16254709 [Abstract] [Full Text] [Related]
5. Effect of pentoxifylline on radiation damage and tumor growth. Vernimmen F, Verheye-Dua F, du Toit H, Böhm L. Strahlenther Onkol; 1994 Oct; 170(10):595-601. PubMed ID: 7974171 [Abstract] [Full Text] [Related]
6. The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. Sagowski C, Tesche S, Zywietz F, Wenzel S, Metternich FU. Onkologie; 2004 Feb; 27(1):54-7. PubMed ID: 15007249 [Abstract] [Full Text] [Related]
7. DNA damage in cultured skin microvascular endothelial cells exposed to gamma rays and treated by the combination pentoxifylline and alpha-tocopherol. Laurent C, Voisin P, Pouget JP. Int J Radiat Biol; 2006 May; 82(5):309-21. PubMed ID: 16782648 [Abstract] [Full Text] [Related]
8. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control. Strunz AM, Peschke P, Waldeck W, Ehemann V, Kissel M, Debus J. Int J Radiat Biol; 2002 Aug; 78(8):721-32. PubMed ID: 12194756 [Abstract] [Full Text] [Related]
9. Physiological mechanisms of radiation sensitization by pentoxifylline. Lee I, Biaglow JE, Lee J, Cho MJ. Anticancer Res; 2000 Aug; 20(6B):4605-9. PubMed ID: 11205310 [Abstract] [Full Text] [Related]
10. Effects of a perfluorochemical emulsion on the response of BA1112 rat rhabdomyosarcomas to continuous low-dose-rate irradiation. Morton JD, Porter E, Yabuki H, Nath R, Rockwell S. Radiat Res; 1990 Nov; 124(2):178-82. PubMed ID: 2123353 [Abstract] [Full Text] [Related]
11. Effects of selenium on radiation responses of tumor cells and tissue. Dörr W. Strahlenther Onkol; 2006 Dec; 182(12):693-5. PubMed ID: 17149574 [Abstract] [Full Text] [Related]
12. The role of pentoxifylline as a modifier of radiation therapy. Nieder C, Zimmermann FB, Adam M, Molls M. Cancer Treat Rev; 2005 Oct; 31(6):448-55. PubMed ID: 16225996 [Abstract] [Full Text] [Related]
13. Combined treatment of rat rhabdomyosarcoma R1H with mitomycin C and X-rays. Baisch H, von Stritzky B. Strahlenther Onkol; 1990 Jun; 166(6):430-4. PubMed ID: 2114041 [Abstract] [Full Text] [Related]
14. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
15. Increase in tumor oxygenation and radiosensitivity caused by pentoxifylline. Song CW, Hasegawa T, Kwon HC, Lyons JC, Levitt SH. Radiat Res; 1992 May 15; 130(2):205-10. PubMed ID: 1574576 [Abstract] [Full Text] [Related]
16. Combined modality treatment of the rhabdomyosarcoma R1H of the rat: tumor and normal tissue response after cisplatin and conventional or accelerated irradiation treatment. Würschmidt F, Beck-Bornholdt HP. Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):391-4. PubMed ID: 7751181 [Abstract] [Full Text] [Related]
17. Protracted exposure radiosensitization of experimental human malignant glioma. Williams JA, Williams JR, Yuan X, Dillehay LE. Radiat Oncol Investig; 1998 May 15; 6(6):255-63. PubMed ID: 9885941 [Abstract] [Full Text] [Related]
18. Changes in tumor oxygenation during a combined treatment with fractionated irradiation and hyperthermia: an experimental study. Zywietz F, Reeker W, Kochs E. Int J Radiat Oncol Biol Phys; 1997 Jan 01; 37(1):155-62. PubMed ID: 9054891 [Abstract] [Full Text] [Related]
19. Effect of subsequent acute-dose irradiation on cell survival in vitro following low dose-rate exposures. Mitchell CR, Joiner MC. Int J Radiat Biol; 2002 Nov 01; 78(11):981-90. PubMed ID: 12456285 [Abstract] [Full Text] [Related]
20. Radiotherapy of the rhabdomyosarcoma R1H of the rat: split-course versus continuous fractionation. Würschmidt F, Beck-Bornholdt HP, Vogler H, Jung H. Strahlenther Onkol; 1991 Jan 01; 167(1):26-30. PubMed ID: 1992539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]